PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-12-16 (1)

Date Title Company
16-Dec-2023 Bristol Myers Squibb Provides Update on RELATIVITY-123 Trial Evaluating the Fixed-Dose Combination of Nivolumab and Relatlimab in Patients with Previously Treated Metastatic Microsatellite Stable (MSS) Colorectal Cancer Businesswire